TTRX

Turn Therapeutics Inc.

Price Chart

No historical data available

Latest Quote

$9.60

-0.24 (-2.44%)

Current Price

Previous Close	$9.84
Open	$9.83
Day High	$10.25
Day Low	$9.53
Volume	31,582

Fetched: 2026-08-31T20:43:48

Stock Information

Shares Outstanding	30.37M
Total Debt	$6.12M
Cash Equivalents	$10.29M
Net Income	$-8.45M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$291.53M
EPS (TTM)	$-0.28
Exchange	NGM

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About Turn Therapeutics Inc.

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

📰 Latest News

No news articles available at the moment. Check back later for updates on TTRX.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31
Revenue
Total Revenue	$0	$0	$0
Operating Revenue	$0	$0	$0
Expenses
Total Expenses	$5,858,648	$1,797,124	$2,308,149
Other Income Expense	$3,131,933	-	-
Other Non Operating Income Expenses	$176,520	-	-
Net Non Operating Interest Income Expense	$-467,365	$28,709	$15,882
Total Other Finance Cost	$496,948	-	-
Operating Expense	$5,858,648	$1,797,124	$2,308,149
General And Administrative Expense	$5,593,078	$1,551,168	$2,300,649
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-3,194,080	$-1,768,415	$-2,292,267
Net Interest Income	$-467,365	$28,709	$15,882
Interest Income	$29,583	$28,709	$15,882
Normalized Income	$-6,149,493	$-1,768,415	$-2,292,267
Net Income From Continuing And Discontinued Operation	$-3,194,080	$-1,768,415	$-2,292,267
Total Operating Income As Reported	$-5,858,648	$-1,797,124	$-2,308,149
Net Income Common Stockholders	$-3,194,080	$-1,768,415	$-2,292,267
Net Income	$-3,194,080	$-1,768,415	$-2,292,267
Net Income Including Noncontrolling Interests	$-3,194,080	$-1,768,415	$-2,292,267
Net Income Continuous Operations	$-3,194,080	$-1,768,415	$-2,292,267
Pretax Income	$-3,194,080	$-1,768,415	$-2,292,267
Interest Income Non Operating	$29,583	$28,709	$15,882
Operating Income	$-5,858,648	$-1,797,124	$-2,308,149
Per Share
Diluted EPS	$-0.12	$-0.06	$-0.08
Basic EPS	$-0.12	$-0.06	$-0.08
Other
Tax Effect Of Unusual Items	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-8,761,315	$-1,749,641	$-2,264,229
Total Unusual Items	$2,955,413	-	-
Total Unusual Items Excluding Goodwill	$2,955,413	-	-
Reconciled Depreciation	$52,746	$47,483	$43,920
EBITDA (Bullshit earnings)	$-5,805,902	$-1,749,641	$-2,264,229
EBIT	$-5,858,648	$-1,797,124	$-2,308,149
Diluted Average Shares	$27,716,045	$29,445,183	$29,445,183
Basic Average Shares	$27,716,045	$29,445,183	$29,445,183
Diluted NI Availto Com Stockholders	$-3,194,080	$-1,768,415	$-2,292,267
Gain On Sale Of Security	$2,955,413	-	-
Research And Development	$265,570	$245,956	$7,500
Selling General And Administration	$5,593,078	$1,551,168	$2,300,649
Other Gand A	$5,593,078	$1,551,168	$2,300,649

Fetched: 2026-08-30

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31
Assets
Net Tangible Assets	$3,764,552	$-999,363	$-684,171
Total Assets	$12,162,241	$2,048,889	$2,013,560
Total Non Current Assets	$6,965,797	$950,965	$811,743
Non Current Prepaid Assets	$8,582	$8,582	$8,582
Non Current Deferred Assets	$5,956,424	$0	-
Goodwill And Other Intangible Assets	$922,171	$821,931	$769,939
Other Intangible Assets	$922,171	$821,931	$769,939
Current Assets	$5,196,444	$1,097,924	$1,201,817
Other Current Assets	$120,300	$225,325	$20,820
Cash Cash Equivalents And Short Term Investments	$5,076,144	$872,599	$1,180,997
Cash And Cash Equivalents	$5,076,144	$872,599	$1,180,997
Debt
Total Debt	$80,376	$121,036	$25,156
Long Term Debt And Capital Lease Obligation	$34,081	$80,376	$0
Current Debt And Capital Lease Obligation	$46,295	$40,660	$25,156
Liabilities
Total Liabilities Net Minority Interest	$7,475,518	$2,226,321	$1,927,792
Total Non Current Liabilities Net Minority Interest	$1,472,094	$1,518,389	$1,438,013
Non Current Deferred Liabilities	$1,438,013	$1,438,013	$1,438,013
Current Liabilities	$6,003,424	$707,932	$489,779
Other Current Liabilities	$3,028,401	-	-
Payables And Accrued Expenses	$2,928,728	$667,272	$464,623
Equity
Common Stock Equity	$4,686,723	$-177,432	$85,768
Total Equity Gross Minority Interest	$4,686,723	$-177,432	$85,768
Stockholders Equity	$4,686,723	$-177,432	$85,768
Other Equity Interest	$-1,070,000	-	-
Retained Earnings	$-22,390,093	$-19,196,013	$-17,427,598
Other
Ordinary Shares Number	$29,445,183	$29,445,183	$29,445,183
Share Issued	$29,445,183	$29,445,183	$29,445,183
Tangible Book Value	$3,764,552	$-999,363	$-684,171
Invested Capital	$4,686,723	$-177,432	$85,768
Working Capital	$-806,980	$389,992	$712,038
Capital Lease Obligations	$80,376	$121,036	$25,156
Total Capitalization	$4,686,723	$-177,432	$85,768
Additional Paid In Capital	$28,143,873	$19,015,897	$17,512,042
Capital Stock	$2,943	$2,684	$1,324
Common Stock	$2,943	$2,684	$1,324
Non Current Deferred Revenue	$1,438,013	$1,438,013	$1,438,013
Long Term Capital Lease Obligation	$34,081	$80,376	$0
Current Capital Lease Obligation	$46,295	$40,660	$25,156
Net PPE	$78,620	$120,452	$33,222
Gross PPE	$78,620	$120,452	$33,222
Other Properties	$78,620	$120,452	$33,222

Fetched: 2026-08-30

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31
Free Cash Flow
Free Cash Flow	$-2,715,887	$-1,460,780	$-1,421,986
Operating Activities
Operating Cash Flow	$-2,562,901	$-1,361,305	$-1,377,680
Cash Flow From Continuing Operating Activities	$-2,562,901	$-1,361,305	$-1,377,680
Operating Gains Losses	$-2,955,413	-	-
Investing Activities
Capital Expenditure	$-152,986	$-99,475	$-44,306
Investing Cash Flow	$-152,986	$-99,475	$-44,306
Cash Flow From Continuing Investing Activities	$-152,986	$-99,475	$-44,306
Financing Activities
Issuance Of Capital Stock	$6,919,432	$1,152,382	$500,000
Financing Cash Flow	$6,919,432	$1,152,382	$500,000
Cash Flow From Continuing Financing Activities	$6,919,432	$1,152,382	$500,000
Net Common Stock Issuance	$6,919,432	$1,152,382	$500,000
Common Stock Issuance	$6,919,432	$1,152,382	$500,000
Other
End Cash Position	$5,076,144	$872,599	$1,180,997
Beginning Cash Position	$872,599	$1,180,997	$2,102,983
Changes In Cash	$4,203,545	$-308,398	$-921,986
Net Intangibles Purchase And Sale	$-152,986	$-99,475	$-44,306
Purchase Of Intangibles	$-152,986	$-99,475	$-44,306
Change In Working Capital	$2,366,481	$-1,856	$229,741
Change In Payables And Accrued Expense	$2,261,456	$202,649	$208,663
Change In Prepaid Assets	$105,025	$-204,505	$1,653
Other Non Cash Items	$498,120	$8,650	$662
Stock Based Compensation	$669,245	$352,833	$640,264
Depreciation Amortization Depletion	$52,746	$47,483	$43,920
Depreciation And Amortization	$52,746	$47,483	$43,920
Gain Loss On Investment Securities	$-2,955,413	-	-
Net Income From Continuing Operations	$-3,194,080	$-1,768,415	$-2,292,267
Change In Other Working Capital	-	-	$19,425

Fetched: 2026-08-30